Thank you for registering for the 4th Glioblastoma Drug Development Summit 2023.
You will shortly be receiving an automatic email confirming your online registration and within the next 24 hours, you will receive your invoice and/or payment confirmation.
If you have any questions about your registration, please contact
Telephone: (+1) 617 455 4188
We look forward to welcoming you to the conference.
Accelerating the Development of More Effective & Precise Oncology Therapies to Targeted Patient Populations
Beacon Cancer Vaccine covers trial and drug records for clinical, preclinical, approved, and discontinued prophylactic and therapeutic cancer vaccines to help you track the cancer vaccine-related clinical trial and drug landscape.